Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: A meta-analysis of randomized, double-blind, placebo-controlled trials

Endoscopy

Volumn 41, Issue 8, 2009, Pages 690-695

  Bai, Y ^a   Xu, C ^a   Yang, X ^a   Gao, J ^a   Zou, D W ^a   Li, Z S ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO;

ARTICLE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INCIDENCE; META ANALYSIS; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CONFIDENCE INTERVAL;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONFIDENCE INTERVALS; HUMANS; INCIDENCE; NITROGLYCERIN; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 70349571915     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0029-1214951     Document Type: Article

References (46)

1. Tsujino T, Isayama H, Komatsu Y, et al. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol 2005 100 38-42
2. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001 96 417-423
3. Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998 48 1-10
4. Freeman M L., DiSario J A., Nelson D B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001 54 425-434
5. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007 102 1781-1788
6. Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc. 2007 65 624-632
7. Bai Y, Gao J, Zou D W., et al. Prophylactic octreotide administration does not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreas 2008 37 241-246
8. Bai Y, Gao J, Shi X, et al. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology 2008 8 504-509
9. Bai Y, Gao J, Zhang W, et al. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Aliment Pharmacol Ther 2008 28 557-564
10. Elmunzer B J., Waljee A K., Elta G H., et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008 57 1262-1267
11. Marsh N, Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol 2000 27 313-319
12. Staritz M, Poralla T, Ewe K, et al. Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut 1985 26 194-197
13. Brandsttter G, Schinzel S, Wurzer H. Influence of spasmolytic analgesics on motility of sphincter of Oddi. Dig Dis Sci 1996 41 1814-1818
14. Staritz M, Poralla T, Dormeyer H H., et al. Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation. Gastroenterology 1985 88 1807-1811
15. Uchida N, Ezaki T, Hirabayashi S, et al. Endoscopic lithotomy of common bile duct stones with sublingual nitroglycerin and guidewire. Am J Gastroenterol 1997 92 1440-1443
16. Wehrmann T, Schmitt T, Stergiou N, et al. Topical application of nitrates onto the papilla of Vater: manometric and clinical results. Endoscopy 2001 33 323-328
17. Sudhindran S, Bromwich E, Edwards P R. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2001 88 1178-1182
18. Moret M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 2003 57 1-7
19. Kaffes A J., Bourke M J., Ding S, et al. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc 2006 64 351-357
20. Schulz K F., Chalmers I, Hayes R J., et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995 273 408-412
21. Moher D, Pham B, Jones A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998 352 609-613 (Pubitemid 28380142)
22. Higgins J PT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK John Wiley & Sons, Ltd 2005
23. Bai Y, Gao J, Zou D W., et al. Prophylactic antibiotics can not reduce infected pancreatic necrosis and mortality in acute necrotizing pancreatitis: evidence from a meta-analysis of randomized controlled trials. Am J Gastroenterol 2008 103 104-110
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 177-188
25. Berlin J A., Laird N M., Sacks H S., et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989 8 141-151
26. Higgins J P., Thompson S G. Quantifying heterogeneity in a metaanalysis. Stat Med 2002 21 1539-1558
27. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997 315 629-634
28. Luman W, Pryde A, Heading R C., et al. Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut 1997 40 541-543
29. Ghori A, Hallisey M, Nwokolo C, et al. The secret (GTN) of successful ERCP cannulation: a prospective randomised controlled study. J R Coll Surg Edinb 2002 47 634-647
30. Murray M A., Kaffes A J., Kwan V, et al. A prospective randomised double blind placebo controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis-final results. J Gastroenterol Hepatol 2003 18 (Suppl) B46
31. Moret M, Zaballa M, Ramrez K, et al. Transdermal glyceryl trinitrate in the prevention of post-ERCP pancreatitis. Gastrointest Endosc 2000 51 AB67
32. Talwar A, Dare C, Pain J. Does topical GTN on the sphincter of Oddi facilitate ERCP? A double-blind randomized control trial. Surg Endosc 2005 19 902-904
33. Njgaard C, Hornum M, Elkjaer M, et al. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, double-blind, placebo-controlled multicenter trial. Gastrointest Endosc 2009 69 e31-e37
34. Beauchant M, Ingrand P, Favriel J M., et al. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Endoscopy 2008 40 631-636
35. Hao J Y., Wu D F., Wang Y Z., et al. Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial. World J Gastroenterol 2009 15 366-368
36. Cotton P B., Lehman G A., Vennes J, et al. Endoscopic sphincterotomy complications and their management. An attempt at consensus. Gastrointest Endosc 1991 37 383-393
37. Moret M, Zaballa M. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 2002 89 628-author reply 629
38. Altman D G. How large a sample? In: Gore SM, Altman DG, eds Statistics in practice. London British Medical Association 1982
39. Normand S L. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999 18 321-359
40. Berlin J A., Santanna J, Schmid C H., et al. Individual patient- versus group-level data meta-regressions for the investigation of treatment effects modifiers: ecological bias rears its ugly head. Stat Med 2002 21 371-387
41. Ioannidis J P., Patsopoulos N A., Rothstein H R. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 2008 336 1413-1415
42. McGovern D PB, Valori R M., Summerskill W SM, et al. Key topics in evidence-based medicine. Oxford BIOS 2001
43. Shao L M., Chen Q Y., Chen M Y., Cai J T. Nitroglycerin in the prevention of post-ERCP pancreatitis: a meta-analysis. Dig Dis Sci 2009 Jan 22 (epub ahead of print)
44. Gilman A G., Goodman L S., Gilman A. Goodman and Gilmans The pharmacological basis of therapeutics. 7th ed. New York Macmillan 1985
45. Birkett D J. Pharmacokinetics made easy: 5: Bioavailability and first pass clearance. Australian Prescriber 1991 14 14-16
46. Testoni P A. Pharmacological prevention of post-ERCP pancreatitis: the facts and the fiction. JOP 2004 5 171-178